VRTX

Vertex Pharmaceuticals Inc

• TipRanks·2h ago

  Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Vertex Pharmaceuticals (VRTX)

• Seeking Alpha·2h ago

  SBIO: Big Pharma Needs What This Fund Owns

• Barron‘s·4h ago

  Vertex's Kidney Drug Success Sparks a 22% Surge for This Rival Biotech

• NASDAQ·5h ago

  Inaxaplin Shows Kidney Benefit In Additional Patient Groups As Vertex Completes Key Trial Enrollment

• Seeking Alpha·5h ago

  Vertex reports positive mid-stage results of inaxaplin for kidney disease

• TipRanks·6h ago

  Analysts Are Bullish on Top Healthcare Stocks: Vertex Pharmaceuticals (VRTX), Maze Therapeutics, Inc. (MAZE)

• TipRanks·6h ago

  Truist sees ‘significant positive readthrough’ for Maze from Vertex data

• TipRanks·6h ago

  Maze jumps 25% to $27.99 after Vertex kidney disease data

• TipRanks·8h ago

  Vertex Pharmaceuticals announces positive results from Phase 2b inaxaplin study

• Benzinga·8h ago

  Vertex Pharmaceuticals Announces Results From Phase 2b AMPLIFIED Study Of Inaxaplin In People With Kidney Disease And Type-2 Diabetes; Treatment With Inaxaplin Led To Reduction In Urine Albumin To Creatinine Ratio Of -42.7% At Week 13 Compared To Baseline; Inaxaplin Was Generally Safe And Well Tolerated In Both Cohorts

• NASDAQ·1d ago

  Notable ETF Inflow Detected - CGGO, WDC, VRTX, AON

• Seeking Alpha·2d ago

  FDA, Duke-Margolis workshop to examine evidence standards for rare diseases

• The Motley Fool·2d ago

  3 Reasons CRISPR Therapeutics Stock Is Still a Buy After a Rocky 2026

• NASDAQ·3d ago

  Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why